ArticleMolecular diagnosis & therapy2020
Mutation Yield of a Custom 212-Gene Next-Generation Sequencing Panel for Solid Tumors: Clinical Experience of the First 260 Cases Tested Using the JAX ActionSeq™ Assay.
Pavalan Selvam et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it